2014
DOI: 10.1007/s10103-014-1551-2
|View full text |Cite
|
Sign up to set email alerts
|

Is carbon dioxide laser vaporization a valuable tool in the management of oral leukoplakia? A survey at an oncology hospital

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
17
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(18 citation statements)
references
References 5 publications
1
17
0
Order By: Relevance
“…On the other hand, although there is no evidence that treatment prevents OL developing into OSCC, the transformation rate can be significantly decreased with CO 2 laser treatment (Yang et al, 2011;Jerjes et al, 2012;Brouns et al, 2013Brouns et al, , 2014Pedrosa et al, 2015;Mogedas-Vegara et al, 2015).…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…On the other hand, although there is no evidence that treatment prevents OL developing into OSCC, the transformation rate can be significantly decreased with CO 2 laser treatment (Yang et al, 2011;Jerjes et al, 2012;Brouns et al, 2013Brouns et al, , 2014Pedrosa et al, 2015;Mogedas-Vegara et al, 2015).…”
Section: Discussionmentioning
confidence: 99%
“…Some authors have used the term cumulative disease-free survival (DFS) in order to avoid confusion in reporting recurrence rates per lesion or per patient. Chiesa et al (1993) reported DFS rates of 70.7% and 51.5% at 3 and 5 years, respectively; Chandu and Smith (2005) reported DFS rates of 55.4% (95% CI; 38.3e72.5) after 3 years and of 33.9% (95% CI; 10.2e57.5) after 5 years; Pedrosa et al (2015) reported an overall DFS rate of 88% after 1-year follow-up. Since it seems that recurrence is unavoidable due to field cancerization, tight follow-up is advisable (Slaughter et al, 1953;Yang et al, 2011;Mogedas-Vegara et al, 2015).…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations